Sexually Transmitted Diseases

Study results suggest that HPV testing is able to detect cervical intraepithelial neoplasia earlier and more accurately than cytology.

Varying dose levels of the GEN-003 vaccine were found to be associated with decreased viral shedding and lesion reduction at up to 1 year post-treatment.

Text messaging is an easy way to improve medication adherence rates, but success depends on a number of factors including youth and race.

A new study conducted by Tufts University School of Medicine identifies gender-specific signatures in gonorrhea infection as well as resistant genes.

Increased testing and education, as well as assistance in financing the cost of care, are clearly needed.

New research finds patients with HIV living in 5 southern states had lower rates of viral suppression and linkage to care compared to people in northern states.

Suicide is a major problem for many patients with infectious diseases but pinpointing the exact cause has proven difficult.

A collection of survey data from 2006 through 2016 found that on average, higher-risk individuals get tested for HIV every 1.4 years.

Individuals with a dense sexual network and a history of antimicrobial drug use, such as men who have sex with men, are at a greater risk for antimicrobial resistance and gonorrhea.

Skin and soft tissue infections appear to be on the decline in the general population, but individuals with HIV have a higher risk.

Early diagnosis and treatment were essential to ensuring a good prognosis.

Researchers have detected herpesviruses, HHV-6A and HHV-7, in the brains of patients diagnosed with Alzheimer’s disease.

In case you missed them, we've compiled the top 5 articles from this past week.

Study results appear to indicate that conceiving while on ART poses a greater risk of stillbirth and miscarriage; however, further analysis revealed a lack of association between ART & poor outcomes.

Implants are promising for long-term, sustained, and reversible delivery of ARV drugs that may bypass adherence challenges for end users.

ViiV Healthcare study results suggest a 2-drug regimen may control HIV in treatment-naïve patients.

Having HIV increases cancer risk, but long-term viral suppression, as well as early treatment, can significantly lower chances of a cancer diagnosis.

A new study reveals that HIV clinicians may not be doing enough to monitor for opioid abuse/misuse among patients.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A higher number of new sexual partners, as well as lifetime sexual partners, may drive this risk in these patients.

A new study looks at the process by which A. fumigatus crosses the airway epithelium, positing a theory involving the use of actin to tunnel into cells.

The results of a new study reveal that rates of viral suppression in women infected with HIV have improved since 2001; however, control of diabetes mellitus has remained poor, regardless of HIV status.

Although most health care providers are adhering to the recommended regimen, the US Centers for Disease Control and Prevention reports that about 20% of patients with uncomplicated gonorrhea are not receiving the recommended dual regimen designed to ward off resistance.

Study data suggest stimulants could be causing the virus to become more active and could expand the HIV reservoirs of patients.

Despite public health recommendations, a new study has found that too many adolescents and young adults in the United States are failing to complete the full vaccination course for HPV.

Study results indicate that starting combination antiretroviral therapy early can stave off further neurological damage associated with HIV infection.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Findings from a recent study find enduring effects of LDH on learning and memory, suggesting potential clinical utility in women with HIV.

Leah H. Rubin, PhD, MPH, MA, discusses the importance of finding ways to improve cognitive function in women who are living with HIV.

The advent of antiretroviral therapy has increased lifespans for those with HIV, meaning there’s a greater need to address the rising incidence of cancer in this aging population.